Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissues. (2014)
Attributed to:
RegenVOX: phase I/II clinical trial of stem cell based tissue engineered laryngeal implants
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2217/rme.14.46
PubMed Identifier: 25431914
Publication URI: http://europepmc.org/abstract/MED/25431914
Type: Journal Article/Review
Volume: 9
Parent Publication: Regenerative medicine
Issue: 6
ISSN: 1746-0751